Canada has lost its measles elimination status after nearly three decades, following a year-long outbreak that the Pan American Health Organization (PAHO) confirmed on Monday. The setback also affects the Americas region, which now loses its measles-free designation.
According to PAHO Director Dr. Jarbas Barbosa, the loss is “reversible” but serves as a warning to strengthen public health efforts. Canada has reported over 5,000 measles cases across nine provinces and one northern territory, with under-vaccinated communities driving the prolonged transmission.
Health experts say the resurgence of measles highlights serious lapses in vaccination outreach and growing vaccine hesitancy since the COVID-19 pandemic. Dr. Isaac Bogoch, an infectious disease specialist at Toronto General Hospital, described the situation as “a wake-up call” for Canada to improve accessibility and trust in immunization programs.
To maintain herd immunity, a 95% vaccination rate is required, as the measles vaccine is 97% effective after two doses. However, declining vaccination rates have allowed the virus to spread more easily, posing severe risks to children and vulnerable populations.
The Public Health Agency of Canada stated that while the spread has slowed, the outbreak persisted for over 12 months. The agency pledged to boost vaccination coverage, strengthen surveillance systems, and improve data sharing nationwide.
In Alberta, one of the hardest-hit provinces, cases have dropped by over 90% from their peak, with vaccination rates up 50% since March. Despite these gains, experts warn that losing measles elimination status is “a step backward,” symbolizing a return to preventable disease risks.
Other countries in the Americas, including the United States, Mexico, and Brazil, are also facing outbreaks as global vaccination rates decline—a concerning trend that could reverse decades of public health progress.


Judge Rules Use of Military Lawyers in Civilian Prosecutions Is Lawful
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
U.S. Fast-Tracks $8.6 Billion Arms Sales to Middle East Allies Amid Rising Tensions
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Australia Launches Public Hearings on Bondi Beach Shooting and Rising Antisemitism
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
FEMA Reinstates Employees After Dissent Letter, Signaling Shift in Workforce Stability
China Banks Halt New Loans to Sanctioned Refineries Amid U.S.-Iran Oil Crackdown
Federal and State Authorities Conduct Widespread Fraud Raids Across Minnesota
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 



